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Background: The value of uric acid in the assessment of renal function and prognosis
in high-risk patients is still unclear and deserves further research. The aim of the
present study is to investigate the relationship between uric acid and estimated
glomerular ﬁltration rate (eGFR) in type 2 diabetic patients combined with coronary
artery disease (CAD) in China.
Methods: From November 2009 to December 2010, we consecutively enrolled 526
patients with type 2 diabetes and CAD and measured plasma levels of uric acid and
creatinine. All patients underwent elective coronary angiography for evaluation of
coronary stenosis and patients with ◎50% stenosis in at least one coronary artery were
considered to have CAD. An eGFR was calculated with the MDRD formula and
patients with eGFR<60 ml/min/1.73 m2 were classiﬁed as having renal dysfunction.
Plasma levels of uric acid, baseline clinical characteristics, and six-month follow-up
results were collected and analyzed. Multivariate logistic regression models were used
to estimate the odds ratios (ORs) for renal dysfunction.
Results: 23 patients were lost and six-month follow-up rate was 95.6%. Uric acid
levels were negatively associated with eGFR (p¼0.002), especially in patients with
renal dysfunction (eGFR<60 ml/min/1.73m2) (r ¼ 쭯0.304, p<0.001). In the highest
quartile of uric acid levels, the risk was substantially higher for reduced renal function
[odds ratio 9.18, (95% conﬁdence interval (CI) 4.01-21.01)] (P < 0.001) compared
with that in the lowest quartile of uric acid levels without adjustment and OR was 9.10
[95% CI 3.93-21.09] after adjustment. Moreover, the similar results remained after
six-month follow-up.
Conclusion: Uric acid levels are negatively associated with eGFR and act as an in-
dependent risk factor for renal dysfunction in patients with type 2 diabetes and CAD.
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Background: Low dose aspirin (LDA) was known to be more frequently associated
with coronary artery spasm (CAS) and ischemic symptoms, as well as severe and
multivessel spasm. The aim of this study was to evaluate the impact of LDA on
clinical outcomes up to 5 years in conﬁrmed CAS patients (pts).
Methods: A total of 5,053 consecutive pts without signiﬁcant coronary artery disease
who underwent acetylcholine (Ach) provocation test from Nov 2004 to Oct 2010 were
enrolled. Among them, a total of 3004 pts were ﬁnally diagnosed as signiﬁcant CAS.
During 5 years, a total of 1,072 pts were followed, and patients were divided into two
groups depending on the use of LDA: LDA group (n¼43 pts) and no LDA group (n¼
1029 pts).
Results: The baseline clinical characteristics showed that the prevalence of old age,
diabetes mellitus, hypertension, and hyperlipidemia were higher in LDA group.
During the Ach test, the incidence of multivessel spasm and the response rate to lower
Ach doses were higher in LDA group. The cumulative clinical outcomes including
mortality, myocardial infarction, and cerebrovascular disease (CVD) up to 5 years
were similar between two groups. However, the incidence of de Novo percutaneous
coronary intervention (PCI), repeated coronary angiogram (CAG) due to recurrent
chest pain, MACE and MACCE were higher in LDA group (Table). Multivariate
analysis showed that LDA was a strong predictor of repeated CAG due to recurrent
chest pain (OR:2.6, 95% CI: 1.4-5.0, p-value¼0.004).
Conclusion: In this study, the CAS patients with use of LDA was related to higher
incidence of 5-year clinical outcomes and LDA was a strong predictor of repeated
CAG due to recurrent chest pain during 5 years, requiring more intensive medical
therapy and close clinical follow up.R
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Background: There have been little data regarding the association between composite
of both left ventricular mass index (LVMI) and LV diastolic function and CACS. The
objective of this study is to determine whether there are association between the
composite of both LVMI and septal E/E’ ratio (E/E’) and coronary artery calcium
score (CACS) severity in subjects with normal LV ejection fraction.
Methods: We investigated 1230 consecutive subjects that CACS, LVMI and E/E’
were measured by coronary computed tomography (CT) and echocardiography.
LVMI and septal E/E’ ratio were compared between the CACS¼0 group and
CACS>0 group. Further, severity of CACS (no, mild, moderate, and severe calciﬁ-
cation) were evaluated according to LVMI and septal E/E’ ratio. According to the
composite of LVMI 90 g/m2 and E/E’ 15, three groups were categorized as fol-
lows; ‘echo scoring system’¼0,1,2.
Results: In multivariate regression analysis, both LVMI, and E/E’ were independent
predictors of CACS>0. Each CACS of the 3 groups was 155.99386.50,
287.51745.52, and 489.00913.49, respectively (p<0.001). In the post hoc anal-
ysis, there was statistically signiﬁcant difference among the three groups. In the
multivariate linear regression analysis, ‘echo scoring system’ was an independent
predictor of CACS.
Conclusion: In our study, LVMI and E/E’ were associated with presence and severity
of CACS. The combination with LVMI and E/E’ can be more accurate predictors of
CASC than LVMI or E/E’ alone.R/High Risk Patients: Diabetes, Heart Failure, Renal Failure, Others S49
